���沙莫瑞林历史与监管定位 — 2026 Update

By Editorial Desk · published 2026-01-28 · last reviewed 2026-02-11 · Faq

A practical reference on GHRH analogue: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2026-02-11 and is reviewed periodically as new material appears.

特沙莫瑞林历史与监管定位

监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。

在临床研究之外，特沙莫瑞林常被讨论为生长激素分泌促进剂，但这一说法需要限定。它并不等同于生长激素本身，也不属于普通减重药物。部分研究关注其减少腹部脂肪和改善脂质谱的潜力，另一些研究则关注胰岛素抵抗和 IGF-1 升高等信号。这些效应的临床意义仍在评估中，尚未形成统一结论。

Mechanism and Pharmacodynamics

Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.

Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.

Tesamorelin at a glance

Background and Clinical Development

Clinical interest in tesamorelin arose from the need to address visceral adiposity in people living with HIV. Antiretroviral therapy improved survival but was associated in some patients with central fat accumulation, altered lipid profiles, and metabolic complications. This condition, often called HIV-associated lipodystrophy, involves excess visceral adipose tissue that is difficult to manage through diet and exercise alone. Investigators evaluated tesamorelin because GHRH analogs can stimulate growth hormone secretion and influence fat distribution without direct liposuction or invasive procedures.

A Phase 3 program led to regulatory approval in the United States in 2010 for reduction of excess visceral abdominal fat in adults with HIV and lipodystrophy. Subsequent studies examined effects on liver fat, muscle area, and metabolic markers, with mixed findings for some endpoints. Long-term cardiovascular outcomes and effects on mortality remain uncertain because most trials were relatively short and focused on imaging-based fat measurements. Use in populations without HIV has been studied experimentally but is not part of the approved indication.

Related pages on this site

• Durable review
• Connected archive
• Smart archive
• Regional summary
• Lightweight overview
• Clear collection
• Scheduled comparison
• Seasonal report

Mechanism And Pharmacodynamic Markers

Whether the drug improves hard clinical outcomes is not settled. No completed trial has shown a reduction in heart attacks or strokes among treated patients, although a dedicated cardiovascular outcomes study has been discussed in the literature. Investigators have also examined hepatic fat in people with HIV and fatty liver disease, cognitive measures in small cohorts, and changes in bone density. Regulatory labeling emphasizes monitoring of insulin-like growth factor 1 because supraphysiologic levels raise questions about tissue growth, and the clinical significance of that signal remains an open question rather than a demonstrated harm.

Binding of tesamorelin to the growth hormone-releasing hormone receptor on anterior pituitary somatotrophs activates a Gs protein pathway, raises cyclic AMP, and triggers release of stored growth hormone into the bloodstream. Because the analogue resists dipeptidyl peptidase-4, its plasma residence time exceeds that of native GHRH, producing a larger and more sustained secretory signal. The released growth hormone then acts on the liver and peripheral tissues to raise insulin-like growth factor 1, which feeds back on the hypothalamus and pituitary. This axis explains both the intended effects on fat distribution and the biological markers used to track them.

Background And Regulatory Development

Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.

Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.

Background from the literature

=== Origin of antiviral resistance === The genetic makeup of viruses is constantly changing, which can cause a virus to become resistant to currently available treatments. Viruses can become resistant through spontaneous or intermittent mechanisms throughout the course of an antiviral treatment. Immunocompromised patients, more often than immunocompetent patients, hospitalized with pneumonia are at the highest risk of developing oseltamivir resistance during treatment. Subsequent to exposure to someone else with the flu, those who received oseltamivir for "post-exposure prophylaxis" are also at higher risk of resistance. The mechanisms for antiviral resistance development depend on the type of virus in question. RNA viruses have high error rates during genome replication because RNA polymerases lack proofreading activity. RNA viruses also have small genome sizes that are typically less than 30 kb, which allow them to sustain a high frequency of mutations. The likelihood of mutations is exacerbated by the speed with which viruses reproduce, which provides more opportunities for mutations to occur in successive replications. Billions of viruses are produced every day during the course of an infection, with each replication giving another chance for mutations that encode for resistance to occur. Multiple strains of one virus can be present in the body at one time, and some of these strains may contain mutations that cause antiviral resistance.

==== Elicitors ==== Pst DC3000 produces a PsINF1, the INF1 in P. syringae. Hosts respond with autophagy upon detection of this elicitor. Liu et al. 2005 finds this to be the only alternative to mass hypersensitivity leading to mass programmed cell death.

Collins correctly identified a photo of Elton John, however Hasselhoff mistook a photo of Debbie Harry for Cyndi Lauper and they were eliminated in the first round with a score of 147. In April 2025, Collins attended the "24 Hour Piano-thon" at Liverpool Street Station which was in promotion of the third series of the Channel 4 music competition show The Piano. Collins played a rendition of Chopsticks on the piano, before performing I Wanna Dance with Somebody (Who Loves Me) by Whitney Houston alongside the Keynotes Choir. In March 2026, after attending the Cheltenham Festival the previous year and not winning anything, Collins returned to the event and ultimately won £20,000 throughout the day, which included £5,000 on one bet after she bet on a horse who won its race with odds of 9/1. In an interview during the ITV Racing coverage, Collins said attending the event had "ignited a fire in her" and encouraged other people, especially women to attend, describing it as "not just a man's sport" and added that she'd probably earn enough money at next year's event to "buy the Cheltenham Racecourse". In April 2026, Collins returned to I'm a Celebrity, 11 years after her original appearance, to take part in the second series of the "All Stars" spin-off I'm a Celebrity... South Africa, which was filmed in September 2025 and featured campmates from previous series.

== Non-surgical alternatives == Lip plumper is a cosmetic product used to make lips appear fuller. These products work by irritating the skin of the lips with ingredients such as capsaicin. This makes the lips swell, temporarily creating the appearance of fuller lips. Suction pumps, a device that uses vacuum pumping to increase blood pressure in the lips, causing temporary swelling.

== Halides == Sulfur reacts with fluorine to give the highly reactive sulfur tetrafluoride and the highly inert sulfur hexafluoride. Whereas fluorine gives S(IV) and S(VI) compounds, chlorine gives S(II) and S(I) derivatives. Thus, sulfur dichloride, disulfur dichloride, and higher chlorosulfanes arise from the chlorination of sulfur. Sulfuryl chloride and chlorosulfuric acid are derivatives of sulfuric acid; thionyl chloride (SOCl2) is a common reagent in organic synthesis. Sulfur halides are precursors to a variety of metal complexes.

Sources: en.wikipedia.org

Reference notes

== Drug development cost == The costs spent on tecemotide development – beginning in the late 1990s – have not been published in detail by the companies Biomira/Oncothyreon, Merck KGaA, and Ono Pharmaceutical. Additionally, the estimation of the full cost of bringing a new drug to market – from discovery through clinical trials to approval – is complex and controversial. However, a cautious estimate of the tecmotide development cost spent until 2014 ranges from €300 to €500 million (US$390 to US$650 million; for more information see Drug development).

Pharmacists, therefore, are considered the experts on drug therapy and are the primary health professionals who optimize the use of medication for the benefit of the patient. In some jurisdictions, such as Colorado, Canada, and Australia, Pharmacists have more liberties to prescribe or adapt/manage prescriptions.. An establishment in which pharmacy (in the first sense) is practiced is called a pharmacy (this term is more common in the United States) or chemists (which is more common in Great Britain, though pharmacy is also used). In the United States and Canada, drugstores commonly sell medicines, as well as miscellaneous items such as confectionery, cosmetics, office supplies, toys, hair care products and magazines, and occasionally refreshments and groceries. In its investigation of herbal and chemical ingredients, the work of the apothecary may be regarded as a precursor of the modern sciences of chemistry and pharmacology, prior to the formulation of the scientific method.

Stanley L. Inhorn (August 1, 1928 – February 19, 2025) was an American physician who was professor of Pathology and Laboratory Medicine at the University of Wisconsin-Madison, where he also served as Director of the Wisconsin State Laboratory of Hygiene (WSLH) on the UW campus. A graduate of Cleveland's Western Reserve University and Columbia University Medical School, Inhorn moved to Madison in 1953 to pursue an internship and residency in pathology before being appointed Assistant Professor of Pathology and Assistant Director of the WSLH in 1960. He became Director of the WSLH in 1966, a position he held until 1979, when he was asked by the UW Medical School to create a Department of Pathology and Laboratory Medicine.

It has a metabolic fate similar to that of codeine. Benzylmorphine is used as the hydrochloride (free base conversion ratio 0.91) and methylsulphonate (0.80) and has a US DEA Administrative Controlled Substance Control Number of 9052.

Sources: en.wikipedia.org

Reference notes

146C → 147N + e− + νe In this form of decay, the original element becomes a new chemical element in a process known as nuclear transmutation. This new element has an unchanged mass number A, but an atomic number Z that is increased by one. As in all nuclear decays, the decaying element (in this case 146C) is known as the parent nuclide while the resulting element (in this case 147N) is known as the daughter nuclide. Another example is the decay of hydrogen-3 (tritium) into helium-3 with a half-life of about 12.3 years:

A mast cell (also known as a mastocyte or a labrocyte) is a resident cell that develops and lives in connective or mucosal tissue and contains many small secretory granules for the storage and release of histamine, heparin and other mediators. Derived from myeloid progenitor cells, mast cells are granulocytes, a type of white blood cell, and part of the immune and neuroimmune systems. Mast cells were described by Friedrich von Recklinghausen in 1863 and rediscovered and named by Paul Ehrlich in 1877. Mast cells act as sentinels, detecting signals that indicate the presence of parasites, pathogens and other possible dangers in surrounding cells and tissues. MCs modulate immune responses according to the stimuli detected, both by releasing mediators stored in granules and by secreting newly synthesized mediators. They play an important protective role in the defense and repair of cells through wound healing, angiogenesis, vascular permeability, and responses to bacteria, viruses, protozoa, prions, fungi, and venoms. MCs are best known for their roles in allergy, anaphylaxis, and atopic dermatitis and may be involved in a variety of other diseases.

In 1881, the Savoy Theatre in the City of Westminster, London was lit by Swan incandescent lightbulbs, which was the first theatre, and the first public building in the world, to be lit entirely by electricity. The first street in the world to be lit by incandescent lamps was Mosley Street, Newcastle upon Tyne, United Kingdom in 1880.

In healthy individuals, this minor pathway – which involves the conversion of L-leucine to α-KIC and then HMB – is the predominant route of HMB synthesis. A small fraction of L-leucine metabolism – less than 5% in all tissues except the testes, where it accounts for about 33% – is initially catalyzed by leucine aminomutase, producing β-leucine, which is subsequently metabolized into β-ketoisocaproate (β-KIC), β-ketoisocaproyl-CoA, and then acetyl-CoA by a series of uncharacterized enzymes. The metabolism of HMB is catalyzed by an uncharacterized enzyme which converts it to β-hydroxy β-methylbutyryl-CoA (HMB-CoA). HMB-CoA is metabolized by either enoyl-CoA hydratase or another uncharacterized enzyme, producing β-methylcrotonyl-CoA (MC-CoA) or hydroxymethylglutaryl-CoA (HMG-CoA) respectively. MC-CoA is then converted by the enzyme methylcrotonyl-CoA carboxylase to methylglutaconyl-CoA (MG-CoA), which is subsequently converted to HMG-CoA by methylglutaconyl-CoA hydratase. HMG-CoA is then cleaved into acetyl-CoA and acetoacetate by HMG-CoA lyase or used in the production of cholesterol via the mevalonate pathway.

==== Other memorials ==== The northwest corner of Bryant Park, at Sixth Avenue and 42nd Street, contains the Heiskell Plaza, a stairway and entrance plaza paved with flagstones. It was placed in 1993 in honor of Andrew Heiskell, a cofounder of the BPC. The southwest corner of Bryant Park, at Sixth Avenue and 40th Street, is known as Nikola Tesla Corner. Tesla, an inventor, lived in the nearby New Yorker Hotel in his later years, and would feed pigeons in the park. The placement of the sign was due to the efforts of the Croatian Club of New York in cooperation with New York City officials, and Ljubo Vujovic of the Tesla Memorial Society of New York.

Sources: en.wikipedia.org

Frequently asked questions